Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
2009 · BMC Genomics · 87 citations
https://doi.org/10.1186/1471-2164-10-301
A
Andrea Worschech
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
1.3K
Citations
18
h-index
23
i10-index
Andrea Worschech is an academic researcher. The author has contributed to research in topics: Immunotherapy and Immune Responses & Virus-based gene therapy research & HER2/EGFR in Cancer Research. The author has an h-index of 18, co-authored 36 publications.
Papers by this author
worksIRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
2013 · British Journal of Cancer · 61 citations
https://doi.org/10.1038/bjc.2013.335
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy
2010 · Journal of Translational Medicine · 42 citations
https://doi.org/10.1186/1479-5876-8-10
Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
2011 · Journal of Translational Medicine · 41 citations
https://doi.org/10.1186/1479-5876-9-170
Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection
2011 · BMC Cancer · 39 citations
https://doi.org/10.1186/1471-2407-11-68
CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer
2010 · Breast Cancer Research and Treatment · 19 citations
https://doi.org/10.1007/s10549-010-0942-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat